Market Place
Sourcing Support
All News #Library
Rare Diseases
Rentschler expands biologics capacity with deal for Shire site
19 Dec 2018 //
FIERCE PHARMA
Shire’s Veyvondi approved in Europe for bleeding disorder
12 Sep 2018 //
PHARMA TIMES
Shire mulls over separation of neuroscience unit
04 Aug 2017 //
PHARMA TIMES
Shire’s Ornskov dictates another big revamp, with R&D/HQ moving into Cambridge
30 Jun 2017 //
ENDPTS
CSL picks up Haegarda orphan drug approval
23 Jun 2017 //
FIERCE PHARMA
No pricing scandal here, say rare disease drugmakers
19 May 2017 //
FIERCE PHARMA
Shire, armed with new rare disease patent, aims to block CSL`s Haegarda launch
17 Apr 2017 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.